DT-216
- Generic Name
- DT-216
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Design Therapeutics, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05573698
- Locations
- 🇺🇸
Clinilabs, Eatontown, New Jersey, United States
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Design Therapeutics, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT05285540
- Locations
- 🇺🇸
Clinilabs, Eatontown, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath